Barnet Hospital is a district general hospital situated in Barnet, in North London. It is managed by the Royal Free London NHS Foundation Trust.

There are 459 beds in Barnet General Hospital.

During the past decade, Barnet General Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barnet General Hospital" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Royal Brompton & Harefield NHS Foundation Trust" with 2 trials sponsored, "University College, London" with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barnet General Hospital" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Barnet and Chase Farm Hospitals NHS Trust" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Barnet General Hospital" are "Coronary Artery Disease" (3 trials), "Breast Cancer" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "Barnet General Hospital" in a lesser frequency.

Most popular intervention types in "Barnet General Hospital" are "Drug" (17 trials), "Procedure" (5 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Sham Procedure" (2 trials), "cyclophosphamide" (2 trials) and "ADT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barnet General Hospital" are 22 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Barnet General Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Barnet General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barnet General Hospital, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".